Additive effects of ezetimibe, evolocumab, and alirocumab on plaque burden and lipid content as assessed by intravascular ultrasound: A PRISMA-compliant meta-analysis-Reference-Cited by-同舟云学术

Additive effects of ezetimibe, evolocumab, and alirocumab on plaque burden and lipid content as assessed by intravascular ultrasound: A PRISMA-compliant meta-analysis

Published:2022-10-14 Issue:41 Volume:101 Page:e31199
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Liang Di,Li Chang,Tu Yanming,Li Zhiyong,Zhang Ming

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.;Diseases;Lancet,2020

2. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.;Roth;J Am Coll Cardiol,2020

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Grundy;Circulation,2019

4. Ezetimibe added to statin therapy after acute coronary syndromes.;Cannon;N Engl J Med,2015

5. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.;Sabatine;N Engl J Med,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on cardiac imaging: A critical analysis;Clínica e Investigación en Arteriosclerosis;2024-09

2. PCSK9 inhibition: from effectiveness to cost-effectiveness;Frontiers in Cardiovascular Medicine;2024-06-25

3. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

4. Cholesterol reduction by immunization with a PCSK9 mimic;Cell Reports;2024-06

5. Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis;Frontiers in Pharmacology;2024-05-13